RT @AurelieRheumo: DISSOLVE 1&2 SEL 212 = tolerogenic nanoparticles containing rapamycin (SEL-110) + pegadricase (S
Tweet Content
DISSOLVE 1&2
SEL 212 = tolerogenic nanoparticles containing rapamycin (SEL-110) + pegadricase (SEL-037)
Meets primary endpoint in 2 RCTs
High dose response 56% & 46%
97% reduction in sUA
Infusion reaction 4%, stomatitis 8%
Anaphylaxis 4 cases
@RheumNow #EULAR23 LB0002 https://t.co/21HieM7NfC
Show on Archive Page
On
Display in Search Results
On
PDQ
Off